Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02669836 · ClinicalTrials.gov registry record · NA
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
A NA study of Syringomyelia and Arnold-Chiari Malformation, Type 1, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT02669836: Completed NA study of Syringomyelia and Arnold-Chiari Malformation, Type 1, sponsored by Washington University School of Medicine.
NCT02669836 is a NA study of Syringomyelia and Arnold-Chiari Malformation, Type 1 that has completed, run by Washington University School of Medicine. The registered enrollment target is 162 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02669836, a NA study of Syringomyelia and Arnold-Chiari Malformation, Type 1, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in better patient outcomes with fewer complications and improved quality of life in those who have Chiari malformation type I and syringomyelia.
Primary Outcome
The number of participants with complications such as: Cerebrospinal fluid (CSF)-related complications ≤6 months (e.g. CSF leak, pseudomeningocele, aseptic meningitis, infection, hydrocephalus), and the requirement for additional surgery for wound revision or CSF diversion
Conditions Studied
Interventions
- PROCEDURE Posterior fossa decompression
- PROCEDURE Dural Augmentation
Study Locations (1)
Missouri
- St. Louis Children's Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT02669836 record still lists
NCT02669836 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 4 conditions, with Syringomyelia appearing as the primary indexed condition, and to 2 interventions - of which Posterior fossa decompression is the first listed.
NCT02669836 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02669836 about?
NCT02669836 is a clinical study titled "Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia". The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in better patient outcomes with fewer complications and improved quality of life in those who have Chiari malformation type I and syringomyelia.
What is the current status of trial NCT02669836?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2016-04. Estimated completion is 2020-07-31.
What conditions does trial NCT02669836 study?
This clinical trial studies the following conditions: Syringomyelia, Arnold-Chiari Malformation, Type 1, Chiari Malformation Type I, Type I Arnold-Chiari Malformation.
What interventions are being tested in trial NCT02669836?
The interventions under investigation include: Posterior fossa decompression (PROCEDURE), Dural Augmentation (PROCEDURE).
Who is sponsoring clinical trial NCT02669836?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02669836 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syringomyelia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02669836's enrollment target sits among peer trials
162 627th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia